Comparison of citrate dialysate in pre- and post-dilution online hemodiafiltration: effect on clot formation and adequacy of dialysis in hemodialysis patients

References

• Canaud B, Bosc JY, Leray H, et al. On-line haemodiafiltration: state of the art. Nephrol Dial Transplant. 1998;13(90005):1–13. doi:10.1093/ndt/13.suppl_5.3.
   Google Scholar
• Canaud B, Bragg-Gresham JL, Marshall MR, et al. Mortality risk for patients receiving hemodiafiltration versus hemodialysis: european results from the DOPPS. Kidney Int. 2006;69(11):2087–2093. doi:10.1038/sj.ki.5000447.
   PubMed Web of Science ®Google Scholar
• Guth HJ, Gruska S, Kraatz G. On-line production of ultrapure substitution fluid reduces TNF-alpha- and IL-6 release in patients on hemodiafiltration therapy. Int J Artif Organs. 2003;26(3):181–187. doi:10.1177/039139880302600301.
   PubMed Web of Science ®Google Scholar
• Canaud B, Wizemann V, Pizzarelli F, et al. Cellular interleukin-1 receptor antagonist production in patients receiving on-line haemodiafiltration therapy. Nephrol Dial Transplant. 2001;16(11):2181–2187. doi:10.1093/ndt/16.11.2181.
   PubMed Web of Science ®Google Scholar
• Carracedo J, Merino A, Nogueras S, et al. On-line hemodiafiltration reduces the proinflammatory CD14 + CD16+ monocyte-derived dendritic cells: a prospective, crossover study. J Am Soc Nephrol. 2006;17(8):2315–2321. doi:10.1681/ASN.2006020105.
   PubMed Web of Science ®Google Scholar
• Lin CL, Yang CW, Chiang CC, et al. Long-term on-line hemodiafiltration reduces predialysis beta-2-microglobulin levels in chronic hemodialysis patients. Blood Purif. 2001;19(3):301–307. doi:10.1159/000046958.
   PubMed Web of Science ®Google Scholar
• Kurihara Y, Hosoya H, Kishihara R, et al. Comparison of the effects of pre-dilution and post-dilution online hemodiafiltration on the levels of inflammatory markers, lymphocytes, and platelets. J Artif Organs. 2022;25(1):59–65. doi:10.1007/s10047-021-01281-5.
   PubMed Web of Science ®Google Scholar
• Tsuchida K, Minakuchi J. Clinical benefits of predilution on-line hemodiafiltration. Blood Purif. 2013;35 (Suppl 1):18–22. doi:10.1159/000346221.
   PubMedGoogle Scholar
• Hottelart C, Achard JM, Moriniere P, et al. Heparin-induced hyperkalemia in chronic hemodialysis patients: comparison of low molecular weight and unfractionated heparin. Artif Organs. 1998;22(7):614–617. doi:10.1046/j.1525-1594.1998.06204.x.
   PubMed Web of Science ®Google Scholar
• Mahmood D, Grubbström M, Lundberg LDI, et al. Lipoprotein lipase responds similarly to tinzaparin as to conventional heparin during hemodialysis. BMC Nephrol. 2010;11(1):33. doi:10.1186/1471-2369-11-33.
   PubMedGoogle Scholar
• Nelson-Piercy C. Heparin-induced osteoporosis. Scand J Rheumatol Suppl. 1998;107:68–71. doi:10.1080/03009742.1998.11720769.
   PubMedGoogle Scholar
• Evenepoel P, Maes B, Vanwalleghem J, et al. Regional citrate anticoagulation for hemodialysis using a conventional calcium-containing dialysate. Am J Kidney Dis. 2002;39(2):315–323. doi:10.1053/ajkd.2002.30551.
   PubMed Web of Science ®Google Scholar
• Kelleher SP, Schulman G. Severe metabolic alkalosis complicating regional citrate hemodialysis. Am J Kidney Dis. 1987;9(3):235–236. doi:10.1016/s0272-6386(87)80061-6.
   PubMed Web of Science ®Google Scholar
• Silverstein FJ, Oster JR, Perez G,O, et al. Metabolic alkalosis induced by regional citrate hemodialysis. ASAIO Trans. 1989;35:22–25.
   PubMedGoogle Scholar
• Grundström G, Christensson A, Alquist M, et al. Replacement of acetate with citrate in dialysis fluid: a randomized clinical trial of short-term safety and fluid biocompatibility. BMC Nephrol. 2013;14(1):216. doi:10.1186/1471-2369-14-216.
   PubMedGoogle Scholar
• Panichi V, Fiaccadori E, Rosati A, et al. Postdilution on-line haemodiafiltration with citrate dialysate: first clinical experience in chronic dialysis patients. ScientificWorldJournal. 2013;2013:703612–703617. doi:10.1155/2013/703612.
   PubMedGoogle Scholar
• Aniort J, Petitclerc T, Créput C. Safe use of citric acid-based dialysate and heparin removal in postdilution online hemodiafiltration. Blood Purif. 2012;34(3-4):336–343. doi:10.1159/000345342.
   PubMed Web of Science ®Google Scholar
• Hays RD, Kallich JD, Mapes DL, et al. Kidney disease quality of life short form (KDQOL-SFTM), vversion 1.3: a manual for use and scoring. Santa Monica, CA, RAND Corporation, 1997).
   Google Scholar
• Ware JE, Keller SD, Kosinski M. SF-36 physical and mental health summary scales: health Assessment Lab Boston 1994).
   Google Scholar
• Tattersall JE, Ward RA, EUDIAL group. Online haemodiafiltration: definition, dose quantification and safety revisited. Nephrol Dial Transplant. 2013;28(3):542–550. Epub 2013 Jan 22. PMID: 23345621. doi:10.1093/ndt/gfs530.
   PubMed Web of Science ®Google Scholar
• Buturovic-Ponikvar J, Gubensek J, Ponikvar R. Citrate anticoagulation for postdilution online hemodialfiltration with calcium-containing dialysate and infusate: significant clotting in the venous bubble trap. Int J Artif Organs. 2008;31(4):323–328. doi:10.1177/039139880803100408.
   PubMedGoogle Scholar
• Peipert JD, Bentler PM, Klicko K, et al. Psychometric properties of the kidney disease quality of life 36-item short-form survey (KDQOL-36) in the United States. Am J Kidney Dis. 2018;71(4):461–468. doi:10.1053/j.ajkd.2017.07.020.
   PubMed Web of Science ®Google Scholar
• Wizemann V. Hemodiafiltration – an avenue to shorter dialysis?. Contrib nephrol. Basel, Karger. 44, 49–56. 1985).
   Google Scholar
• Trakarnvanich T, Sirivongrangson P, Trongtrakul K, et al. The effect of citrate in cardiovascular system and clot circuit in critically ill patients requiring continuous renal replacement therapy. J Artif Organs. 2022;26(1):53–64. doi:10.1007/s10047-022-01329-0.
   PubMed Web of Science ®Google Scholar
• Trakarnvanich T, Thirathanakul S, Sriphueng N, et al. The effect of citrate on clot formation, dialyzer reuse, and anemia in hemodialysis patients. Blood Purif. 2019;47(4):361–368. doi:10.1159/000495025.
   PubMed Web of Science ®Google Scholar
• Uchino S, Fealy N, Baldwin I, et al. Pre-dilution vs post-dilution during continuous venovenous hemofiltration: impact on filter life and azotemic control. Nephron Clin Pract. 2003;94(4):c94–c98. doi:10.1159/000072492.
   PubMedGoogle Scholar
• Van der Voort PH, Gerritsen RT, Kuiper MA, et al. Filter run time in CVVH: pre-versus postdilution and nadroparin versus regional heparin-protamine anticoagulation. Blood Purif. 2005;23(3):175–180. doi:10.1159/000083938.
   PubMed Web of Science ®Google Scholar
• Brain MJ, Roodenburg OS, Adams N, et al. Randomised trial of software algorithm driven regional citrate anticoagulation versus heparin in continuous renal replacement therapy: the filter life in renal replacement therapy pilot trial. Crit Care Resusc. 2014;16(2):131–142. doi:10.1016/S1441-2772(23)01454-0.
   PubMed Web of Science ®Google Scholar
• Schmitz M, Loke O, Fach B, et al. Effects of citrate dialysate in chronic dialysis: a multicentre randomized crossover study. Nephrol Dial Transplant. 2016;31(8):1327–1334. doi:10.1093/ndt/gfv347.
   PubMed Web of Science ®Google Scholar
• Quinaux T, Pongas M, Guissard É, et al. Comparison between citrate and acetate dialysate in chronic online hemodiafiltration: a short-term prospective study in pediatric settings. Nephrol Ther. 2020;16(3):158–163. doi:10.1016/j.nephro.2019.12.002.
   PubMed Web of Science ®Google Scholar
• Richtrova P, Mares J, Kielberger L, et al. Citrate-buffered dialysis solution (citrasate) allows avoidance of anticoagulation during intermittent hemodiafiltration-at the cost of decreased performance and systemic biocompatibility. Artif Organs. 2017;41(8):759–766. doi:10.1111/aor.12851.
   PubMed Web of Science ®Google Scholar
• Šafránek R, Moučka P, Vávrová J, et al. Changes of serum calcium, magnesium and parathyroid hormone induced by hemodialysis with citrateenriched dialysis solution. Kidney Blood Press Res. 2015;40(1):13–21. doi:10.1159/000368478.
   PubMed Web of Science ®Google Scholar
• Molina Nuñez M, de Alarcón R, Roca S, et al. Citrate versus acetate-based dialysate in on-line haemodiafiltration. A prospective cross-over study. Blood Purif. 2015;39(1-3):181–187. doi:10.1159/000371569.
   PubMed Web of Science ®Google Scholar
• Pizzarelli F, Cantaluppi V, Panichi V, et al. Citrate high volume on-line hemodiafiltration modulates serum interleukin-6 and klotho levels: the multicenter randomized controlled study "hephaestus. J Nephrol. 2021;34(5):1701–1710. doi:10.1007/s40620-020-00943-6.
   PubMed Web of Science ®Google Scholar
• Kimmel PL, Patel SS. Quality of life in patients with chronic kidney disease: focus on end-stage renal disease treated with hemodialysis. Semin Nephrol. 2006;26(1):68–79. doi:10.1016/j.semnephrol.2005.06.015.
   Google Scholar
• ElHafeez SA, Sallam SA, Gad ZM, et al. Cultural adaptation and validation of the “kidney disease and quality of life-short form (KDQOL-SF™) version 1.3” questionnaire in Egypt. BMC Nephrol. 2012;13(1):170. doi:10.1186/1471-2369-13-170.
   PubMedGoogle Scholar
• DeOreo PB. Hemodialysis patient-assessed functional health status predicts continued survival, hospitalization, and dialysis-attendance compliance. Am J Kidney Dis. 1997;30(2):204–212. doi:10.1016/s0272-6386(97)90053-6.
   PubMed Web of Science ®Google Scholar
• Hasan LM, Shaheen DAH, El Kannishy GAH, et al. Is health-related quality of life associated with adequacy of hemodialysis in chronic kidney disease patients? BMC Nephrol. 2021;22(1):334. doi:10.1186/s12882-021-02539-z.
   PubMed Web of Science ®Google Scholar
• Merkus MP, Jager KJ, Dekker FW, et al. Quality of life in patients on chronic dialysis: self-assessment 3 months after the start of treatment. Am J Kidney Dis. 1997;29(4):584–592. doi:10.1016/S0272-6386(97)90342-5.
   PubMed Web of Science ®Google Scholar